Armour signals constructive MBS outlook amid Fed easing and 7.75% economic return
Armour signals constructive MBS outlook amid Fed easing and 7.75% economic return
Category: finance
289-Powered 1965 Ford Mustang Fastback 4-Speed
This 1965 Ford Mustang is a red-over-black fastback that was modified under previous ownership with a retrofitted 289ci V8, four-speed manual transmission, and 8″ rear end. 15″ American Racing Torq Thrust wheels, front disc brakes, stainless-steel headers, an aluminum radiator, a Pro Comp intake manifold, grille lights, a wood-rimmed steering wheel, and Rally Pac gauges were also installed. The seller acquired the car on BaT in March 2023, and has since fitted a replacement Bluetooth-capable radio and sound system, replaced the door panels, retrofitted power windows and LED headlights, and rebuilt the carburetor. This Mustang is now offered with a clean Florida title in the seller’s name.
PG& E reports mixed Q3 results; initiates FY26 and narrows FY25 EPS outlook
PG& E reports mixed Q3 results; initiates FY26 and narrows FY25 EPS outlook
CZ Reveals Real Reason Tokenized Gold Has Not Taken Off
Binance Founder Changpeng Zhao believes tokenized gold relies too much on trust, a move that is against modern finance innovation.
Cross Timbers Royalty Trust declares $0.0752 dividend
Cross Timbers Royalty Trust declares $0.0752 dividend
Bitcoin Braces for First Inflation Test Since US Shutdown
Analysts expects a measured market reaction to Friday’s CPI report, noting that tariff concerns and labor data outweigh the inflation print.
Barclays Initiates Coverage of Celldex Therapeutics (CLDX) With an Underweight Rating
Celldex Therapeutics, Inc. (NASDAQ:CLDX) is one of the best small cap stocks with the highest upside. Barclays initiated coverage of Celldex Therapeutics, Inc. (NASDAQ:CLDX) with an Underweight rating on October 13, assigning a $25 price target to the shares. The rating came as part of the firm’s launch of eight companies across rare diseases, inflammation […]
Purple Biotech announces receipt of Nasdaq minimum bid price notification
Purple Biotech announces receipt of Nasdaq minimum bid price notification
Paramount Skydance (PSKY) Stock: Rises as $2B Cost-Cutting Plan Sparks Investor Optimism
TLDRs; Paramount Skydance (PSKY) stock rose 1. 3% after unveiling a $2 billion cost-reduction strategy. The restructuring includes 2, 000 job cuts in the U. S. and additional international layoffs. Over half of the cost savings will be realized in the first year, totaling 7% of the combined cost base. Investors view the plan as a sign of [.] The post Paramount Skydance (PSKY) Stock: Rises as $2B Cost-Cutting Plan Sparks Investor Optimism appeared first on CoinCentral.